JOHN MASSEY: Open Payments
NPI 1922063528 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,730 in 60 payments from 11 companies in 2025. Trend: 2023 $1,451 · 2024 $4,607 · 2025 $3,730
Food & beverage: $2,294Travel & lodging: $1,437
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 9 | $2,329 |
| Boston Scientific Corporation | 29 | $909 |
| MML US, Inc. | 6 | $130 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $101 |
| ABBVIE INC. | 4 | $100 |
| SI-BONE, INC. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| SPR Therapeutics, Inc | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Indivior Inc. | 1 | $17 |
Products named: Evoke, Intracept, General - Pain Management, WaveWriter Alpha Prime 16, ReActiv8, UBRELVY, General - Therapies, Belbuca.
Industry payments across NE — which companies pay providers there.
